Application Nr Approved Date Route Status External Links
NDA202379 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Abiraterone Acetate Is Indicated In Combination With Prednisone For The Treatment Of Patients With Metastatic Castration-Resistant Prostate Cancer (Crpc) Metastatic High-Risk Castration-Sensitive Prostate Cancer (Cspc) Abiraterone Acetate Is A Cyp17 Inhibitor Indicated In Combination With Prednisone For The Treatment Of Patients With Metastatic Castration-Resistant Prostate Cancer (Crpc). ( 1 ) Metastatic High-Risk Castration-Sensitive Prostate Cancer (Cspc). ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Abiraterone Acetate ABIRATERONE ACETATE ZINC5224164

Comments